244
Views
4
CrossRef citations to date
0
Altmetric
Articles

Risk factors for HIV positivity among more than 3,400 Tanzanian women

, MSc, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , PhD, , PhD, DMSc & , MD, DMSc show all
Pages 650-664 | Received 18 Nov 2015, Accepted 29 May 2016, Published online: 14 Jul 2016

References

  • Aubin, F., J.-L. Pretet, A.-C. Jacquard, M. Saunier, X. Carcopino, F. Jaroud, P. Pradat, et al.; for the EDiTH Study Group. 2008. Human papillomavirus genotype distribution in external acuminata condylomata: A large French national study (EDiTH IV). Clinical Infectious Diseases 47:610–15.
  • Auvert, B., D. Marais, P. Lissouba, K. Zarca, G. Ramjee, and A.-L. Williamson. 2011. High-risk human papillomavirus is associated with HIV acquisition among South African female sex workers. Infectious Diseases in Obstetrics and Gynecology 2011:692012.
  • Bosch, F. X., A. N. Burchell, M. Schiffman, A. R. Giuliano, S. De Sanjosé, L. Bruni, G. Tortolero-Luna, S. K. Kjaer, and N. Munoz. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26 (Suppl 10):K1–16.
  • Dartell, M., V. Rasch, C. Kahesa, J. Mwaiselage, T. Ngoma, J. Junge, A. Gernow, et al. 2012. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: The PROTECT study. Sexually Transmitted Diseases 39:201–08.
  • Denny, L. A., S. Franceschi, S. De Sanjosé, I. Heard, A. B. Moscicki, and J. Palefsky. 2012. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 30 (Suppl 5):F168–74.
  • Frazer, I. H. 2009. Interaction of human papillomaviruses with the host immune system: A well evolved relationship. Virology 384:410–14.
  • Gallagher, K. E., K. Baisley, H. Grosskurth, A. Valley, S. Kapiga, J. Vandepitte, A. Kamali, et al. 2016. The association between cervical human papillomavirus infection and subsequent HIV acquisition in Tanzanian and Ugandan women: A nested case-control study. Journal of Infectious Diseases 214:87–95.
  • Houlihan, C. F., N. L. Larke, D. Watson-Jones, K. K. Smith-McCune, S. Shiboski, P. E. Gravitt, J. S. Smith, L. Kuhn, C. Wang, and R. Hayes. 2012. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. Aids 26:2211–22.
  • Iftner, T., and L. L. Villa. 2003. Human papillomavirus technologies. Journal of the National Cancer Institute Monographs 31:80–88.
  • Johnson, K., and A. Way. 2006. Risk factors for HIV infection in a national adult population: Evidence from the 2003 Kenya Demographic and Health Survey. Journal of Acquired Immune Deficiency Syndromes 42:627–36.
  • Kimanga, D. O., S. Ogola, M. Umuro, A. Ng’ang’a, L. Kimondo, P. Murithi, J. Muttunga, et al.; for the KAIS Group. 2014. Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15–64 years in Kenya: Results from a nationally representative study. Journal of Acquired Immune Deficiency Syndromes 66 (Suppl 1):S13–26.
  • Kjaer, S. K., G. Breugelmans, C. Munk, J. Junge, M. Watson, and T. Iftner. 2008. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. International Journal of Cancer 123:1864–70.
  • Lemme, F., A. M. Doyle, J. Changalucha, A. Andreasen, K. Baisley, K. Maganja, D. Watson-Jones, S. Kapiga, R. J. Hayes, and D. A. Ross. 2013. HIV infection among young people in Northwest Tanzania: The role of biological, behavioral and socio-demographic risk factors. Plos One 8:e66287.
  • Lissouba, P., P. Van de Perre, and B. Auvert. 2013. Association of genital human papillomavirus infection with HIV acquisition: A systematic review and meta-analysis. Sexually Transmitted Infections 89:350–56.
  • Low, A. J., T. Clayton, I. Konate, N. Nagot, A. Ouedraogo, C. Huet, M.-N. Didelot-Rosseau, M. Segondy, P. Van de Perre, and P. Mayaud; for the Yérélon Cohort Study Group. 2011. Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: A longitudinal study. BMC Infectious Diseases 11:20.
  • Mermin, J., J. Musinguzi, A. Opio, W. Kirungi, J. P. Ekwaru, W. Hladik, F. Kaharuza, R. Downing, and R. Bunnell. 2008. Risk factors for recent HIV infection in Uganda. The Journal of the American Medical Association 300:540–49.
  • Mmbaga, E. J., A. Hussain, G. H. Leyna, K. S. Mnyika, N. E. Sam, and K.-I. Klepp. 2007. Prevalence and risk factors for HIV-I infection in rural Kilimanjaro region of Tanzania: Implications for prevention and treatment. BMC Public Health 7:58.
  • Munoz, N., F. X. Bosch, S. De Sanjosé, R. Herrero, X. Castellsagué, K. V. Shah, P. J. F. Snijders, and C. J. L. M. Meijer; for the IARC Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine 348:518–27.
  • Quigley, M., K. Munguti, H. Grosskurth, J. Todd, F. Mosha, K. Senkoro, J. Newell, et al. 1997. Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: A case-control study. Aids 11:237–48.
  • Rositch, A. F., L. Mao, M. G. Hudgens, S. Moses, K. Agot, D. M. Backes, E. Nyagaya, et al. 2014. Risk of HIV acquisition among circumcised and uncircumcised young men with penile human papillomavirus infection. Aids 28:745–52.
  • Silverberg, M. J., L. Ahdieh, A. Munoz, K. Anastos, R. D. Burk, S. Cu-Uvin, A. Duerr, et al. 2002. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sexually Transmitted Diseases 29:427–35.
  • Smith, J. S., S. Moses, M. Hudgens, C. B. Parker, K. Agot, I. Maclean, J. O. Ndinya-Achola, P. J. F. Snijders, C. J. L. M. Meijer, and R. C. Bailey. 2010. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. The Journal of Infectious Diseases 201:1677–85.
  • Smith-McCune, K. K., S. Shiboski, M. Z. Chirenje, T. Magure, J. Tuveson, Y. Ma, M. Da Costa, et al. 2010. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PloS One 5:e10094.
  • Stanley, M. 2006. Immune responses to human papillomavirus. Vaccine 24 (Suppl 1):S16–22.
  • Todd, J., H. Grosskurth, J. Changalucha, A. Obasi, F. Mosha, R. Balira, K. Orroth, et al. 2006. Risk factors influencing HIV infection incidence in a rural African population: A nested case-control study. The Journal of Infectious Diseases 193:458–66.
  • UNAIDS (Joint United Nations Programme on HIV/AIDS). 2014. The Gap Report. Geneva, Switzerland. http://www.unaids.org/en/resources/documents/2014/ (accessed June 19, 2015).
  • Van de Velde, N., M.-C. Boily, M. Drolet, E. L. Franco, M.-H. Mayrand, E. V. Kliewer, F. Coutlée, J.-F. Laprise, T. Malagon, and M. Brisson. 2012. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: A model-based analysis. Journal of the National Cancer Institute 104:1712–23.
  • Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. F. Snijders, J. Peto, C. J. L. M. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 189:12–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.